Clinical Trial Update: CIML NK Cells With Venetoclax for AML [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of CIML NK Cells with Venetoclax for Acute Myeloid Leukemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CIML NK Cells
• Venetoclax (venetoclax)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent | Phase 1 | Status: RECRUITING